These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1977245)

  • 1. Schizophrenia: a neurotransmitter imbalance syndrome?
    Carlsson A
    Yakubutsu Seishin Kodo; 1990 Mar; 10(1):35-42. PubMed ID: 1977245
    [No Abstract]   [Full Text] [Related]  

  • 2. Schizophrenia: a subcortical neurotransmitter imbalance syndrome?
    Carlsson M; Carlsson A
    Schizophr Bull; 1990; 16(3):425-32. PubMed ID: 1981107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of dopamine in schizophrenia.
    Guillin O; Abi-Dargham A; Laruelle M
    Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of dopaminergic, cholinergic, and glutamatergic mechanisms in the actions of phencyclidine-like drugs.
    Johnson KM; Snell LD
    NIDA Res Monogr; 1986; 64():52-66. PubMed ID: 3086740
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tremor and motility following oxotremorine and harmine in rats with lesions of the nigro-striatal system].
    Westermann KH; Oelszner W; Staib AH; Funk K
    Acta Biol Med Ger; 1974; 33(1):67-76. PubMed ID: 4153886
    [No Abstract]   [Full Text] [Related]  

  • 6. [A biochemical theory of schizophrenia].
    Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
    Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptides in the basal ganglia.
    Graybiel AM
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():135-61. PubMed ID: 2425403
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
    Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
    J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physiopathology of schizophrenia. Some biologic aspects].
    Tissot R
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(1):29-40. PubMed ID: 6148787
    [No Abstract]   [Full Text] [Related]  

  • 10. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?
    Kondziella D; Brenner E; Eyjolfsson EM; Sonnewald U
    Neurochem Int; 2007 Jan; 50(2):291-301. PubMed ID: 17084946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia.
    Creese I; Hess EJ
    Clin Neuropharmacol; 1986; 9 Suppl 4():14-6. PubMed ID: 2882838
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glutamatergic hypothesis of schizophrenia: psychoses induced by phencyclidine and cortical-subcortical imbalance].
    Krebs MO
    Encephale; 1995; 21(5):581-8. PubMed ID: 8529568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications.
    Carlsson A; Hansson LO; Waters N; Carlsson ML
    Life Sci; 1997; 61(2):75-94. PubMed ID: 9217267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA receptors inhibit the mild hypoxia-induced dopamine efflux in the rat striatum.
    Orset C; Parrot S; Sauvinet V; Cottet-Emard JM; Pequignot JM; Denoroy L
    Synapse; 2006 Jun; 59(7):458-61. PubMed ID: 16523475
    [No Abstract]   [Full Text] [Related]  

  • 16. A glutamatergic deficiency model of schizophrenia.
    Carlsson A; Hansson LO; Waters N; Carlsson ML
    Br J Psychiatry Suppl; 1999; (37):2-6. PubMed ID: 10211132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A; Guillin O
    Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas.
    Perry KW; Falcone JF; Fell MJ; Ryder JW; Yu H; Love PL; Katner J; Gordon KD; Wade MR; Man T; Nomikos GG; Phebus LA; Cauvin AJ; Johnson KW; Jones CK; Hoffmann BJ; Sandusky GE; Walter MW; Porter WJ; Yang L; Merchant KM; Shannon HE; Svensson KA
    Neuropharmacology; 2008 Oct; 55(5):743-54. PubMed ID: 18602930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Brain monoamines and the increase in motor activity in the rat after amphetamine.
    Guldberg HC; Marsden CA
    Br J Pharmacol; 1972 Feb; 44(2):347P-348P. PubMed ID: 4668615
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple opioid receptor systems in brain and spinal cord: Part 2.
    Yaksh TL
    Eur J Anaesthesiol; 1984 Sep; 1(3):201-43. PubMed ID: 6152614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.